StockGuru News: Genesis Technology Group, Inc. (OTCBB: GTEC) – Genesis Partner Lotus Pharmaceuticals Forecasts Sales Exceeding $50 Million From Catalog of Current and Future Drugs
Genesis Technology Group, Inc. (OTCBB: GTEC) Genesis Partner Lotus Pharmaceuticals Forecasts Sales Exceeding $50 Million From Catalog of Current and Future Drugs BOCA RATON, Fla., July 25, 2007 — Genesis Technology Group, Inc. (OTCBB: GTEC) announced that its Chinese partner, Lotus Pharmaceuticals, released its catalog of drugs that projects sales exceeding $50 million. Lotus (OTC BB:LTUS.OB - News), recently joined by Gold Horse International, Inc. (OTC BB:SPEH.OB - News), reached public company status in 2006 as a member of the Genesis private-to-public program. Genesis maintains an active role in both companies, as an advisor to management and participant on their…